a clinical diagnosis made bench side after two years

A Clinical Diagnosis Made Bench Side after Two Years

A Comparison of Fundamental Performance between Two Bench Top Clinical Chemistry Analyzers

Oligobodies: bench made synthetic antibodies.

Using synthetic peptides and a combinatorial library of 56 mer random oligonucleotides, we have developed reagents that behave as "synthetic antibodies". The results obtained with the protein phosphatase 2A as a model system are shown here. The specificity of these reagents, named "oligobodies", has been demonstrated by Western blot analysis and immunohistochemistry. The oligobodies have enormo...

Moss‐made pharmaceuticals: from bench to bedside

Over the past two decades, the moss Physcomitrella patens has been developed from scratch to a model species in basic research and in biotechnology. A fully sequenced genome, outstanding possibilities for precise genome-engineering via homologous recombination (knockout moss), a certified GMP production in moss bioreactors, successful upscaling to 500 L wave reactors, excellent homogeneity of p...

Skeletal aging: from bench to bed side.

In this special issue of the Journal of Gerontology: Series A, we have invited experts in the fields of basic bone biology and clinical osteoporosis to review the current stage of our understanding of basic cellular and molecular mechanisms of skeletal aging, the appropriate animal models to study the process, the pathogenesis of age-related bone loss in humans, the latest clinical research on ...

Diagnostic Pathology – after two years

With the second anniversary of Diagnostic Pathology approaching, this Editorial looks at the journal's achievements so far and outlines the prospects and challenges.